Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Prognostic Impact of Subclinical FLT3 -ITD Microclones in Patients with Acute Myeloid Leukemia

Paul Olson, Razif Gabdoulline, Rabia Shahswar, Arnold Kloos, Letizia Venturini, Isabell Arnhardt, Henri C. Hupe, Victoria Panagiota, Michael Stadler, Matthias Eder, Gernot Beutel, Elke Dammann, Piroska Poll, Anke Bergmann, Nataliya DiDonato, Florian H. Heidel, Felicitas R. Thol, Michael Heuser

Blood (2024) 144 (Supplement 1): 847.

https://doi.org/10.1182/blood-2024-207703

Published: 2024

Journal Articles

Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation

Clara Philine Wienecke, Bennet Heida, Letizia Venturini, Razif Gabdoulline, Katja Krüger, Katrin Teich, Konstantin Büttner, Martin Wichmann, Wolfram Puppe, Blerina Neziri, Marlene Reuter, Elke Dammann, Michael Stadler, Arnold Ganser, Lothar Hambach, Felicitas Thol, Michael Heuser

Blood (2024) 144 (3): 296–307.

https://doi.org/10.1182/blood.2023022697

Published: 2024

Includes: Supplemental data

Journal Articles

Treatment and Disease Characteristics of Chronic Myeloid Leukemia in Blast Crisis: The European Leukemianet Blast Crisis Registry

Blood (2022) 140 (Supplement 1): 818–820.

https://doi.org/10.1182/blood-2022-162252

Published: 2022

Journal Articles

T Regulatory Cell Receptor Repertoire Focusing and Clonal Expansion Indicates Control of Acute GvHD after Donor Lymphocyte Infusion

Christian R Schultze-Florey, MD, Leonie Kuhlmann, cand. MD, Solaiman Raha, PhD, Ivan Odak, MSc, Saleh Tavil, cand. MD, Melanie Drenker, Elke Dammann, Lothar Hambach, Steve Ehrlich, MD, Michael Stadler, MD PhD, Michael Heuser, MD, Felicitas Thol, MD, Reinhold Foerster, DVM, PhD, Arnold Ganser, MD, Immo Prinz, PhD, Christian Koenecke

Blood (2018) 132 (Supplement 1): 822.

https://doi.org/10.1182/blood-2018-99-116083

Published: 2018

Journal Articles

TCR Diversity Is a Predictive Marker for Donor Lymphocyte Infusion Response

Christian Schultze-Florey, MD, Solaiman Raha, Sarina Ravens, PhD, Leonie Kuhlmann, Melanie Drenker, Linda Oberdörfer, Anke Breithaupt, Elke Dammann, Lothar Hambach, MD, Michael Stadler, MD, Michael Heuser, MD, Felicitas Thol, MD, Reinhold Foerster, Prof., Arnold Ganser, MD, Immo Prinz, Prof., Christian Koenecke, MD

Blood (2016) 128 (22): 4605.

https://doi.org/10.1182/blood.V128.22.4605.4605

Published: 2016

Journal Articles

Molecular Predictors of Outcome in Patients with MDS and AML Following MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2015) 126 (23): 912.

https://doi.org/10.1182/blood.V126.23.912.912

Published: 2015

Journal Articles

Prognostic Impact Of a Newly Defined Structurally Complex Karyotype In Patients With AML and MDS After Allogeneic Stem Cell Transplantation

Christiane E Dobbelstein, MD, Elke Dammann, Eva M Weissinger, MD, Michael Stadler, MD, Matthias Eder, MD, Brigitte Schlegelberger, MD, PhD, Arnold Ganser, MD, Gudrun Gohring, MD

Blood (2013) 122 (21): 3362.

https://doi.org/10.1182/blood.V122.21.3362.3362

Published: 2013

Journal Articles

Graft Versus Leukemia With Little Graft Versus Host Disease? Long Term Follow-Up Of a Study Using Transduced Donor T-Cells For Donor Leukocyte Transfusion

Eva M Weissinger, MD, Sylvia Borchers, PhD, Justyna Ogonek, MSc, Kriti Verma, MSc, Steve Ehrlich, MD, Christian Koenecke, MD, Patrick Schweier, Chiara Bonini, MD, Fabio Ciceri, Elke Dammann, Susanne Luther, Jürgen Krauter, Prof. Dr. med., Michael Stadler, MD, Arnold Ganser

Blood (2013) 122 (21): 4207.

https://doi.org/10.1182/blood.V122.21.4207.4207

Published: 2013

Journal Articles

Prognostic Effect of Mutations in the Splicing Gene Machinery in 339 Patients with MDS or Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2012) 120 (21): 357.

https://doi.org/10.1182/blood.V120.21.357.357

Published: 2012

Journal Articles

Persistence of Recipient-Derived Antiviral T cells Severely Influence Donor Chimerism Post Allogeneic HSCT,

Sylvia Borchers, PhD, Michael Stadler, MD, Susanne Luther, Tina Ganzenmueller, Brigitte Pabst, Stefanie Buchholz, MD, Elke Dammann, Arnold Ganser, MD, Eva M Weissinger, MD

Blood (2011) 118 (21): 3240.

https://doi.org/10.1182/blood.V118.21.3240.3240

Published: 2011

Journal Articles

Prospective Validation of a Chronic GvHD-Specific Proteome Pattern (cGvHD-MS14) Post Allogeneic Hematopoietic Stem Cell Transplantation

Eva M. Weissinger, MD, Daniel Wolff, Jochen Metzger, Christiane E Dobbelstein, MD, Stefanie Buchholz, MD, Elke Dammann, Uwe Borchert, Annika Krons, Helmut Diedrich, Michael Stadler, MD, Anne M Dickinson, PhD, Ernst Holler, M.D., Hildegard T. Greinix, MD, Juergen Krauter, MD, Arnold Ganser, MD

Blood (2011) 118 (21): 1970.

https://doi.org/10.1182/blood.V118.21.1970.1970

Published: 2011

Journal Articles

Proteomic Pattern-Based Risk Stratification of Outcome Shows Significant Higher Accuracy Compared to HCT-CI in Patients with AML and MDS,

Christiane E Dobbelstein, MD, Jochen Metzger, Elke Dammann, Uwe Borchert, Stefanie Buchholz, MD, Michael Stadler, MD, Matthias Eder, MD, Juergen Krauter, MD, Arnold Ganser, MD, Eva Mischak-Weissinger, MD

Blood (2011) 118 (21): 4128.

https://doi.org/10.1182/blood.V118.21.4128.4128

Published: 2011

Journal Articles

Prognostic Effect of ASXL1 Mutations in Patients with MDS and Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation

Christian Koenecke, MD, Felicitas Thol, MD, Patrick Löffeld, Stefanie Buchholz, MD, Michael Stadler, MD, Gudrun Göhring, MD, Elke Dammann, Moritz Kleine, MD, Wiebke Brauns, Michael Hallensleben, MD, Jörg Schmidtke, MD, Brigitte Schlegelberger, M.D., Jürgen Krauter, Arnold Ganser, MD, Michael Heuser, M.D.

Blood (2011) 118 (21): 1709.

https://doi.org/10.1182/blood.V118.21.1709.1709

Published: 2011

Journal Articles

Long Term Results of Allogeneic Hematopoietic Cell Transplantation in Elderly Patients.

Michael Stadler, MD, Elke Dammann, Stefanie Buchholz, MD, Bernd Hertenstein, MD, Juergen Krauter, MD, Matthias Eder, MD, Arnold Ganser, MD

Blood (2009) 114 (22): 3388.

https://doi.org/10.1182/blood.V114.22.3388.3388

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.

Blood (2009) 114 (22): 1209.

https://doi.org/10.1182/blood.V114.22.1209.1209

Published: 2009

Journal Articles

Circulating Angiopoietin-2 Predicts Time to Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.

Christian Koenecke, MD, Philipp Kümpers, MD, Alexander Lukasz, Hartmut Hecker, MD, Elke Dammann, Willem Verhagen, MD, Sascha David, MD, Gudrun Göhring, MD, Stefanie Buchholz, MD, Eva Weissinger, MD, PhD, Jürgen Krauter, MD, Ph.D., Matthias Eder, MD, Ph.D., Hermann Haller, MD, Ph.D., Arnold Ganser, MD, PhD

Blood (2008) 112 (11): 3259.

https://doi.org/10.1182/blood.V112.11.3259.3259

Published: 2008

Journal Articles

Extramedullary Acute Leukemias prior to and after Allogeneic Hematopoietic Stem Cell Transplantation: a Single Center Study.

Michael Stadler, MD, PhD, Helmut Diedrich, MD, Elke Dammann, Stefanie Buchholz, MD, Eva Mischak-Weissinger, MD, PhD, Juergen Krauter, MD, PhD, Matthias Eder, MD, PhD, Arnold Ganser, MD, PhD

Blood (2008) 112 (11): 3262.

https://doi.org/10.1182/blood.V112.11.3262.3262

Published: 2008

Journal Articles

Lower Relapse Incidence and Relapse Mortality in Patients Transplanted from a Younger Sibling in HLA-Identical Stem Cell Transplantation: Does Microchimerism Matter?

Christiane Dobbelstein, MD, Haytham Kamal, MD, Elke Dammann, Eva Mischak-Weissinger, MD, PhD, Michael Stadler, MD, PhD, Juergen Krauter, MD, PhD, Arnold Ganser, MD, PhD, Matthias Eder, MD, PhD

Blood (2008) 112 (11): 343.

https://doi.org/10.1182/blood.V112.11.343.343

Published: 2008

Journal Articles

Improved Outcome for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Poor Risk Cytogenetics – Result from An Analysis on 172 Patients Receiving FLAMSA-RIC Conditioning for Allogeneic Stem Cell Transplantatioin (SCT).

Blood (2008) 112 (11): 1971.

https://doi.org/10.1182/blood.V112.11.1971.1971

Published: 2008

Journal Articles

FLAMSA Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in High Risk Myeloid Malignancies Is Also Feasible with Partially Mismatched Donors.

Michael Stadler, MD, Elke Dammann, Stefanie Buchholz, MD, Bernd Hertenstein, MD, Juergen Krauter, MD, Matthias Eder, MD, Arnold Ganser, MD

Blood (2007) 110 (11): 3068.

https://doi.org/10.1182/blood.V110.11.3068.3068

Published: 2007

NARROW

Prognostic Impact of Subclinical FLT3 -ITD Microclones in Patients with Acute Myeloid Leukemia

Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation

Treatment and Disease Characteristics of Chronic Myeloid Leukemia in Blast Crisis: The European Leukemianet Blast Crisis Registry

T Regulatory Cell Receptor Repertoire Focusing and Clonal Expansion Indicates Control of Acute GvHD after Donor Lymphocyte Infusion

TCR Diversity Is a Predictive Marker for Donor Lymphocyte Infusion Response

Molecular Predictors of Outcome in Patients with MDS and AML Following MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic Impact Of a Newly Defined Structurally Complex Karyotype In Patients With AML and MDS After Allogeneic Stem Cell Transplantation

Graft Versus Leukemia With Little Graft Versus Host Disease? Long Term Follow-Up Of a Study Using Transduced Donor T-Cells For Donor Leukocyte Transfusion

Prognostic Effect of Mutations in the Splicing Gene Machinery in 339 Patients with MDS or Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation

Persistence of Recipient-Derived Antiviral T cells Severely Influence Donor Chimerism Post Allogeneic HSCT,

Prospective Validation of a Chronic GvHD-Specific Proteome Pattern (cGvHD-MS14) Post Allogeneic Hematopoietic Stem Cell Transplantation

Proteomic Pattern-Based Risk Stratification of Outcome Shows Significant Higher Accuracy Compared to HCT-CI in Patients with AML and MDS,

Prognostic Effect of ASXL1 Mutations in Patients with MDS and Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation

Long Term Results of Allogeneic Hematopoietic Cell Transplantation in Elderly Patients.

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.

Circulating Angiopoietin-2 Predicts Time to Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.

Extramedullary Acute Leukemias prior to and after Allogeneic Hematopoietic Stem Cell Transplantation: a Single Center Study.

Lower Relapse Incidence and Relapse Mortality in Patients Transplanted from a Younger Sibling in HLA-Identical Stem Cell Transplantation: Does Microchimerism Matter?

Improved Outcome for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Poor Risk Cytogenetics – Result from An Analysis on 172 Patients Receiving FLAMSA-RIC Conditioning for Allogeneic Stem Cell Transplantatioin (SCT).

FLAMSA Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in High Risk Myeloid Malignancies Is Also Feasible with Partially Mismatched Donors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only